Product NDC: | 49884-949 |
Proprietary Name: | Megace ES |
Non Proprietary Name: | megesterol acetate |
Active Ingredient(s): | 125 mg/mL & nbsp; megesterol acetate |
Administration Route(s): | ORAL |
Dosage Form(s): | SUSPENSION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 49884-949 |
Labeler Name: | Par Pharmaceutical, Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021778 |
Marketing Category: | NDA |
Start Marketing Date: | 20050702 |
Package NDC: | 49884-949-69 |
Package Description: | 150 mL in 1 BOTTLE (49884-949-69) |
NDC Code | 49884-949-69 |
Proprietary Name | Megace ES |
Package Description | 150 mL in 1 BOTTLE (49884-949-69) |
Product NDC | 49884-949 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | megesterol acetate |
Dosage Form Name | SUSPENSION |
Route Name | ORAL |
Start Marketing Date | 20050702 |
Marketing Category Name | NDA |
Labeler Name | Par Pharmaceutical, Inc |
Substance Name | MEGESTROL ACETATE |
Strength Number | 125 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Progesterone Congeners [Chemical/Ingredient],Progestin [EPC] |